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It is now recognised that mixed viral infection, or infection of an individual with two or more distinct strains of a single viral
species, often occurs particularly with RNA viruses. Current methods for detection of mixed infection normally involve
genotyping or cloning and DNA sequencing. These methods are not always accurate or sensitive at detecting mixed infection
and cannot be used for large numbers of samples. Furthermore subsequent sequence determination of the coinfecting
viruses is labour intensive. This paper describes a simple, generic method based upon PCR and heteroduplex mobility
analysis (HMA) that can be used to rapidly determine mixed infection with two strains of the same virus. The utility of this
method is illustrated with hepatitis C virus (HCV) and TT virus (TTV) as examples. PCR–HMA detected mixed infection in 3
(8%) of 38 sera from intravenous drug users (IVDU) and 28 (30%) of 70 TTV-positive sera from Australia, China, and Vietnam.
HMA can also be used to screen recombinant colonies to identify the sequences of the coinfecting viruses. The methods
described here could be applied to analyse any PCR product containing two or more divergent sequences, whether derived
from viruses, bacteria, or eukaryotic organisms. © 2000 Academic PressINTRODUCTION
Assessments of viral infection and antiviral agents
often ignore the possibility of mixed infection, as current
methods are suboptimal for accurate and rapid detection
of this phenomenon (Tuveri et al., 1997). Mixed infection
is infection of an individual with two or more distinct
strains of the one viral species. Recent data indicate
mixed infection is common in many viral infections, in-
cluding with Hepatitis C virus (HCV) (Tuveri et al., 1997),
hepatitis D virus (Wu et al., 1999), human immunodefi-
ciency virus (HIV) (Takehisa et al., 1998), and TT virus
(TTV) (Ball et al., 1999; Forns et al., 1999; Okamoto et al.,
1999; Takayama et al., 1999). Mixed viral infection may
result in more severe disease, may confound assess-
ment of response to antiviral therapy and should be
considered when interpreting quantitative nucleic acid
amplification of viruses, such as in HIV or HCV infection,
where the quantitation may vary between genotypes.
Sera from Australian intravenous drug users (IVDU)
were examined in this study for mixed infection with
different genotypes of HCV. HCV is a highly variable
positive-stranded RNA virus and is the major cause of
non-A, non-B hepatitis (Choo et al., 1989; Kuo et al., 1989).
Mixed infection with two HCV genotypes has been de-
tected in 1% of HCV-positive patients, using type-specific
primers (Holland et al., 1996; Okamoto et al., 1992). This
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382may be an inaccurate assessment, as primer-specific
genotyping can overestimate mixed infection of subtypes
1a and 1b due to nonspecific annealing of core primers
(Tuveri et al., 1997). Genotyping studies of multitrans-
fused haemophiliacs suggest that the rate of HCV mixed
infection is high in this group with reported rates of 31%
(Isobe et al., 1995), 12% (Fujimura et al., 1996), and 14 and
7% by serotype and genotype analysis, respectively
(Preston et al., 1995).
The DNA virus TT virus (TTV) was also analysed for its
ability to cause mixed infections. TTV was isolated in
1997 from the serum of a patient with posttransfusion
hepatitis of unknown aetiology using representational
difference analysis (Nishizawa et al., 1997). The virus is a
nonenveloped, circular, negative-stranded virus of 3852
nucleotides (Mushahwar et al., 1999). Two reports sug-
gest that the virus is related to the Circoviridae (Mush-
ahwar et al., 1999; Miyata et al., 1999) that are known to
infect plants and vertebrates.
When mixed infection is present, PCR amplification of
target sequences results in two heterologous double-
stranded DNA products of similar molecular mass. When
these heterologous products are denatured and allowed
to anneal, the original PCR products reanneal to form
homoduplexes. During annealing, the formation of two
hybrid DNA molecules also occurs, termed heterodu-
plexes. Heteroduplexes contain one DNA strand derived
from each of the two double-stranded products, and if
the sequences of these strands differ, mismatches occur.









383DETECTION OF MIXED INFECTION USING HMAseparate the heteroduplexes from the homoduplexes by
polyacrylamide gel electrophoresis (PAGE) since the for-
mation of mismatches cause the heteroduplexes to mi-
grate with reduced mobility. The reduction in mobility or
gel shift is proportional to the divergence between the
two sequences (White et al., 1999; Delwart et al., 1993).
herefore the presence of heteroduplexes indicates the
resence of two viruses, i.e., mixed infection. The HMA
echnique detects nucleotide divergence as low as 2–4%
lthough slightly lower variability can be detected if nu-
leotide insertions or deletions are present (White et al.,
999; Delwart et al., 1993).
Current methods of determining the sequence and/or
genotype of coinfecting viruses involve cloning the PCR
product, sequencing an arbitrary number of these clones
(usually 10), and comparing the sequences. This process
is time consuming and potentially fruitless if mixed in-
FIG. 1. Cloning strategy for PCR products suspected of containing
heterologous sequences due to mixed infection. Step 1: products are
cloned into pGEM-T. Step 2: colonies are simultaneously stored in
microtitre plates and subjected to PCR amplification of inserts. Step 3:
HMA screening of PCR-amplified inserts from cloned PCR products.
For HCV, lane 1 shows the reference product, and lanes 2–6 show HMA
between this reference and five colony PCR products. For TTV, lane 7
shows the reference product, and lanes 8–12 show HMA between this
reference and five colony PCR products. HMA reveals products diver-
gent to the references in lanes 4, 10, and 11. The reference products
and products from lanes 4 and 10 were subsequently sequenced (Step
4) and aligned to demonstrate the percentage divergence between the
co-infecting sequences (Step 5). Lanes M contained molecular size
markers.fection is not present or sampling is of insufficient levels
to detect mixed infection especially if one virus is
present at low levels. A second application for the PCR–
HMA method is described where HMA screening of
recombinant colonies is used to identify the sequences
of the coinfecting viruses. This is a useful and rapid
alternative to DNA sequencing for colony screening,
once cloning has been performed (Fig. 1).
Using HCV and TTV as examples, a generic method
based upon PCR and heteroduplex mobility analysis
(HMA) is described that can be used to rapidly determine
mixed infection with two strains of the same virus. The
methodology described here could be applied to analyse
any PCR product that contains two or more divergent
sequences whether derived from virus, bacteria, or eu-
karyotic cells.
RESULTS
HMA detection of mixed infection and analysis using
cloned products
HMA of 59-UTR products from the five main genotypes
can be used to identify heteroduplexes between HCV
genotypes 1-2, 1-3, 1-6, 2-3, 2-6, 3-4, 3-6, and 4-6, but not
between genotypes 1-4 and 2-4 (White et al., 2000). We
herefore hypothesised that mixed infection could be
etected using HMA of PCR products from the 59-UTR. A
number of control experiments demonstrated this, and
results are shown in Figs. 2–4. HCV 59-UTR products
from HCV genotypes 1b, 2b, 3a, and 6a were cloned into
pGEM-T. Cloned DNA was then amplified from the bac-
teria by colony PCR, mixed in a pair-wise fashion, and
subjected to HMA. Mixed infection could be detected as
cloned products from different genotypes formed hetero-
duplexes that were clearly identified using HMA (Fig. 2).
No heteroduplexes were seen in lanes containing a
single genotype (Fig. 2, lanes 1, 5, 8, and 10) or when
mixing cloned products of the same subtype that di-
FIG. 2. Ethidium-bromide-stained 8% polyacrylamide gels showing
pair-wise HMA between subtypes 1a, 2b, 3a, and 6a, amplified from
bacteria containing HCV sequences cloned into pGEM-T. Subtypes
used in the pair-wise analysis are shown along the top. Heterodu-
plexes formed between HCV subtypes appear as bands with reduced
mobilities in the gel, and no heteroduplexes are seen in lanes contain-
ing single genotypes. Lane M contains molecular size markers.verged by between 1 and 4 bp (data not shown). South-
ern blots probed with an oligonucleotide that hybridised
r384 WHITE ET AL.to the central portion of the PCR product confirmed the
heteroduplexes were HCV PCR products (data not
shown).
The sensitivity of RT–PCR and HMA detection of mixed
infection was determined by mixing sera containing
equal amounts of HCV subtypes 1a and 3a (assessed by
measurement of viral load) in different proportions (Fig.
3). Subsequently RNA was extracted, HCV was detected
by RT–PCR, and products were tested by HMA at each
concentration of subtype 1a and 3a. When subtype 1a
represents only 1% (3 3 102 copies) and subtype 3a
epresented 99% (3 3 104 copies), mixed infection was
still detected by HMA (Fig. 3, lane 4). The same sensi-
tivity was found when subtype 1a represented 99% and
subtype 3a represented 1% of the viraemia (data not
shown). However, mixed infection could not be detected
by RT–PCR and HMA when the proportion of one coin-
fecting genotype was 0.2% (Fig. 3, lane 5). The proportion
of coinfecting genotype within the amplified product that
can be detected was determined by combining genotype
2b and 6a PCR products in different ratios and subjecting
the mixture to HMA. Mixed infection was detected even
if the coinfecting virus represented only 2% of the ampli-
fied product (Fig. 4, lanes 2 and 12) and at ratios of 10%
heteroduplexes were clearly seen (Fig. 4, lane 4).
Ten TTV ORF1 PCR products representing genotypes
1a, 1b (3 clones), 2a, 2c (2 clones), 3, and 4 (2 clones)
were cloned into pGEM-T. Cloned DNA was then ampli-
FIG. 3. Ethidium-bromide-stained 8% polyacrylamide gel showing the
HMA limit of detection of mixed HCV infection in sera. HCV viral load
was quantified, and different proportions of serum containing subtype
1a were mixed with serum containing subtype 3a. RNA was extracted
from the sera, and RT–PCR detection of HCV was carried out. PCR
products were denatured, allowed to reanneal, and separated by PAGE.
The percentage proportions of 1a template DNA are shown along the
top, where 100% 5 3 3 104 copies. Lane M contains molecular size
markers.
FIG. 4. Ethidium-bromide-stained 8% polyacrylamide gel showing the
was amplified from bacteria containing HCV sequences, by PCR direc
with subtype 6a amplicons and subjected to HMA. The proportions w
DNA in each reaction was equal). The percentage of 2b amplicon in the
2b and 6a before denaturation/annealing, and lane 15 shows subtype 2b fol
present. Lane M contains molecular size markers.fied from the bacteria by colony PCR, mixed in a pair-
wise approach, and subjected to HMA. HMA of isolates
of the same subtype demonstrating ,6% divergence did
not demonstrate heteroduplexes (see Fig. 5, lane 2 for an
example). The TTV ORF1 PCR product varies by .30%
between genotypes (Okamoto et al., 1998), which is sig-
nificantly higher than variation between HCV 59-UTR
products from different genotypes (4–19%). This in-
creased divergence is reflected in a greater reduction in
mobility of heteroduplexes seen for different TTV geno-
types compared to HCV genotypes (Fig. 5). Moreover for
TTV, HMA was able to identify coinfecting subtypes as
well as genotypes.
HMA detection of mixed HCV infection
A cohort of 38 Australian IVDUs was chosen for geno-
type analysis by sequencing amplicons derived from the
HCV 59-UTR. Sequencing identified 68.4% as genotype 1
and 21% as subtype 3a, and one patient was genotype 2b
(2.6%) (Table 1). Repeat electropherograms from two in-
dividuals exhibited overlapping peaks suggestive of
mixed infection. HMA was carried out to detect mixed
HCV infection on all 38 amplicons and compared with
detection of HMA for mixed infection using PCR products. Cloned DNA
colonies. Different proportions of subtype 2b amplicons were mixed
ermined from the volume of PCR reaction used (where the amount of
ample (2b and 6a) is shown along the top. Lane 14 contains subtypes
FIG. 5. Ethidium-bromide-stained 8% polyacrylamide gel showing
examples of HMA of TTV sequences amplified from bacteria containing
ORF1 sequences cloned into pGEM-T. Subtype mixtures studied are
shown along the top. No heteroduplexes are seen in lane 1, which
contains a single subtype 1b, or in lane 2, which shows a mixture of two
different 1b subtypes. Lane 3 shows heteroduplexes formed between
TTV subtypes 1a and 1b as bands with reduced mobilities. Further
reduction in mobility is seen with HMA between genotypes 1b and 2a





lowing denaturation/annealing; in both cases, no heteroduplexes are
385DETECTION OF MIXED INFECTION USING HMAthe identification of mixed infection on the basis of PCR
sequencing results. HMA revealed heteroduplexes with
reduced mobilities in three samples (Fig. 6, lanes 2, 4,
and 6), two of which corresponded to the sequence data
and one of which was not detected by PCR and sequenc-
ing. HMA did not reveal heteroduplexes in all other 35
products; an example of a negative result is shown in
Fig. 6, lanes 7 and 8. No heteroduplexes were identified
in lanes that contained untreated PCR products (Fig. 6).
Two bands were noted in lane 3 (untreated products),
which indicates two different mobilities for the two dif-
ferent HCV amplicons. Therefore HMA was able to de-
tect mixed infection in 7.9% of sera from IVDUs.
HMA detection of mixed TTV infection
In a larger survey to assess the use of the PCR–HMA
technique with a different virus, 70 TTV ORF1 amplicons
from Australian, Chinese, and Vietnamese individuals
were screened for mixed infection using HMA. HMA of
PCR products revealed a high prevalence of individuals
infected with more than one TTV genotype. This included
27.8% (5/18) of Australian individuals, 66.7% (8/12) of
Chinese individuals, and 20% (8/40) of Vietnamese indi-
viduals, and typical examples are shown in Fig. 7. Het-
eroduplexes are clearly seen after denaturation/anneal-
ing (lanes, 2, 4, 6, 8, 10, 12, 14, and 16) in Patients A–H.
Patient I shows an example of infection with a single
genotype where no heteroduplexes are present after
denaturation/annealing (Fig. 7, lane 18). These results
indicate a high level of mixed infection in TTV-infected
individuals, consistent with data from other publications
(Ball et al., 1999; Forns et al., 1999; Okamoto et al., 1999;
Takayama et al., 1999).
Assessment of the genotypes of viruses causing
mixed infection by HMA screening and sequencing
Following cloning of the PCR product, a second appli-
cation for the PCR–HMA method is to use rapid HMA
screening of recombinant colonies to determine the se-
quence and subsequent genotype or subtype of the
coinfecting viruses, as shown in Fig. 1. Sequence anal-
TABLE 1
Distribution of Hepatitis C Virus (HCV) Subtypes in Australian
Intravenous Drug Users





Mixed infection 3 7.9ysis of six HCV clones (Fig. 8) demonstrated that the
HCV-positive patients were coinfected with subtypes 1a-2a/c, 1b-2b (as seen in Fig. 1), and 1a-3a (Fig. 8). Se-
quence analysis of the six TTV clones indicated that
patients were coinfected with genotypes 1a-1b (12.2%
nucleotide difference, Fig. 1), 1b-4 (32.4% nucleotide dif-
ference), and 2c and 4 (32.9% nucleotide difference) (Fig.
8).
DISCUSSION
In this study, we have shown that mixed infection of
one individual with two different genotypes of the same
species of virus can be rapidly and inexpensively deter-
mined using HMA. The sequence divergence of PCR
products amplified from the two coinfecting viruses is a
key factor when using HMA for the detection of mixed
infection. In a previous study, we determined that the
limit of resolution of the technique using 8% PAGE gels
electrophoresed at 110 V for 100 min was between 3 and
4% sequence divergence (White et al., 1999). Lower res-
olution limits are possible when gels are electropho-
resed for much longer—Wilson and co-workers
achieved a resolution limit of 1.7% divergence using 18 h
at 400 V (Wilson et al., 1995), and Calvo et al. achieved a
resolution of 1.4% divergence using 16 h at 500 V on 6%
gels (Calvo et al., 1998). Therefore, if divergence between
products amplified from co-infecting genotypes demon-
strates less than the resolution limit of the HMA tech-
nique described here (3–4%), then heteroduplexes will
not be separated from homoduplexes, and the presence
of mixed infection will not be detected.
Detecting mixed infection relies upon adequate ampli-
fication of both viral species. It is critical that primers
designed to detect mixed infection bind optimally to all
genotypes; thereby the efficiency of PCR amplification of
each co-infecting virus is equal. Lau and co-workers
suggested that direct sequencing of PCR products would
only identify mixed infection if one variant represented
.10–20% of the HCV genome targets amplified (Lau et
al., 1995). We found mixed infection was difficult to iden-
tify by sequencing; conversely, HMA was found to be a
FIG. 6. Ethidium-bromide-stained 8% polyacrylamide gels showing
mixed infection in 3 of 38 HCV patients. Patient numbers are indicated
along the bottom. PCR products are shown before denaturation and
annealing (odd lanes) and after (even lanes); the presence of hetero-
duplexes in even lanes indicates the presence of mixed infection (lanes
2, 4, and 6). Lanes 7 and 8 show a typical result seen with all other 35
products. Lane M contains molecular size markers (pGEM-3 cut with





























































386 WHITE ET AL.more sensitive, simpler, and more accurate method to
determine mixed infection. Using the methods described
here, mixed infection could still be detected even when
the co-infecting virus represented 1% of either viral pop-
ulation in the serum or 2% of the amplified product.
Mixed HCV infection detected by HMA should not be
confused with the presence of quasispecies. The diver-
gence between subtypes (.20%) and genotypes (.30%)
s much greater than that seen between quasispecies
,5%) over the whole HCV genome. Since sequence
ivergence in the 59-UTR (5–19%) is less than over the
hole genome, the variation between quasispecies is
orrespondingly lower. Therefore quasispecies will not
e detected if highly conserved regions of the genome
re amplified as the divergence between minor quasi-
pecies and the dominant sequence would be lower
han the resolution limit. Moreover, if highly variable
pecies were present within the viral population, it is
ikely that they will be present at low frequencies and
herefore not detected.
The clinical outcome of mixed HCV infections is vari-
ble. One study demonstrated that mixed infection was
ransient in seven haemophiliac patients followed for #7
ears (Fujimura et al., 1996). Studies of mixed infection in
CV-positive recipients of HCV-infected kidneys suggest
he new infecting HCV strain results in varying virological
atterns in the host—replacement with the new strain,
ersistence of the old strain, or long-standing mixed
nfection (Widell et al., 1995). There are few studies of the
ffect of mixed infection on the outcome of HCV-infected
ndividuals partly because of the difficulty in detecting
ixed infection in large numbers of patients. Widell and
o-workers demonstrated a more aggressive disease in
wo of five HCV-positive patients, super-infected follow-
ng receipt of HCV-infected kidneys (Widell et al., 1995).
Mixed infection has infrequently been reported for
NA viruses. The rate of mixed infection is high for TTV,
FIG. 7. HMA detection of mixed infection in TTV-positive sera from Au
showing eight examples of mixed infection as identified by HMA. Patie
indicate samples that were subsequently cloned and sequenced (Fig. 8
after (even lanes); the presence of heteroduplexes in even lanes indicat
infection is present.ith two or more TTV genotypes infecting an individual
Ball et al., 1999; Forns et al., 1999; Takayama et al., 1999;
l
Vhis study). Study of TTV infection in seven haemophili-
cs showed three patients were infected with three dif-
erent genotypes, three with four genotypes, and one
ith five genotypes (Takayama et al., 1999). Recent pa-
ers demonstrate a very high prevalence of TTV in Asia
hat could account for high rates of mixed infections in
ome samples, particularly if faeco-oral transmission
as common (Prescott et al., 1998; Takahashi et al., 1998;
anaka et al., 1998). Mixed infection could indicate that
TV is not readily cleared from an individual, that rein-
ection is frequent, spread by nonparenteral routes is
mportant, and/or that the virus has exceptionally high
utational rates. Furthermore, infection with multiple
TV genotypes also suggests infection with one isolate
oes not protect against subsequent infections, particu-
arly if the incoming virus is of a different genotype.
In this study, we have described a rapid, more repre-
entative, simpler, and less expensive method for detect-
ng and analysing mixed viral infections that could also
e useful for analysis of any PCR product containing
ore than one sequence. Large numbers of viral sam-
les can be analysed, and subsequent sequencing and
enotyping of viral clones is made faster by HMA selec-
ion following colony–PCR. This method can be used to
elp gain a better understanding of the impact of mixed
nfections on the pathogenesis of viral infections. Fur-
hermore, the method could easily adapted to detecting




HCV-positive sera were obtained from 38 Australian
VDUs. TTV-positive sera were obtained from 18 Austra-
China, and Vietnam. Ethidium-bromide-stained 8% polyacrylamide gels
bers are shown along the bottom, and those marked with an asterisk
roducts are shown before denaturation and annealing (odd lanes) and
d infection. Lanes 17 and 18 show a typical result seen when no mixedstralia,
nt num






387DETECTION OF MIXED INFECTION USING HMANucleic acid extraction and PCR techniques
TTV DNA and HCV RNA were extracted from serum
using a modification of standard techniques (Chomczyn-
ski and Sacchi, 1987) as described previously (White et
al., 1999). Combined reverse transcription (RT) and PCR
FIG. 8. Sequence analysis of PCR products of coinfecting viruses. P
lignments are shown of the three HCV mixed infections; Patient 1 wa
ith 1a and 3a. Sequence analysis of the six TTV clones indicated
ifference, Fig. 1), Patient F with genotypes 1b and 4 (32.4% nucleo
ifference).amplification (RT–PCR) of the HCV 59-untranslated region
(59-UTR) were performed as described previously (Whiteet al., 2000). TTV was detected using a modification of a
hemi-nested PCR (Okamoto et al., 1998) with primer, hep
49 (59-TAC CAY TTD GCT CTC ATT-39), replacing NG061
as the reverse primer in the outer PCR. HCV viral load
was determined using the AMPLICOR MONITOR assay
according to manufacturer’s instructions (Roche Diag-
age differences between coinfecting virus are indicated. (A) Pair-wise
ed with subtypes 1a and 2a/c, Patient 2 with 1b and 2b, and Patient 3
tient A was coinfected with genotypes 1a and 1b (12.2% nucleotide
ference), and Patient G with genotypes 2c and 4 (32.9% nucleotideercent
s infect














388 WHITE ET AL.fied from bacteria by colony PCR (Gussow and Clackson,
1989). In brief, a small portion of bacteria containing the
cloned product was added to 30 ml of water and boiled
or 10 min, and 2 ml was used as template for PCR.
Heteroduplex mobility analysis (HMA)
For HMA, 5 ml of PCR product was used to detect
mixed infection, and 2 ml of reference and sample PCR
roducts were mixed for analysis of cloned products.
amples were denatured for 5 min at 94°C and allowed
o anneal at 50°C for 30 min. Heteroduplexes and ho-
oduplexes were separated by PAGE for 100 min at 100
on 8% nondenaturing gels containing 0.5% PEG. Gels
ere stained with ethidium bromide and visualised un-
er ultraviolet light.
MA screening of recombinant colonies
HMA detection of mixed infection was confirmed by
loning PCR products into pGEM-T (Fig. 1, Step 1). Six
olonies were inoculated into microtitre wells containing
00 ml of LB medium and into tubes containing 30 ml of
water (Fig. 1, Step 2). Colonies in water were boiled, and
2 ml was used as template for colony–PCR. The first
clone (inoculated into well A1) was used as the reference
in the HMA and mixed with PCR products generated
from the other clones (Fig. 1, Step 3). Sequencing the
reference clone, and any clone forming a heteroduplex
with the reference, identified the sequences of the two
cloned PCR products derived from the coinfecting vi-
ruses (Fig. 1, Step 4). For example in Fig. 1, clones
sequenced were in lanes 1 and 4 for HCV and in lanes 7
and 10 for TTV. The two sequences were then aligned to
determine the divergence between the coinfecting vi-
ruses (Fig. 1, Step 5).
Southern blotting, DNA sequencing, and sequence
analysis
Southern blots were carried using standard proce-
dures (Sambrook et al., 1989). A biotinylated probe,
hep57 (59-AAC CGG TGA GTA CAC CGG AAT-39), that
binds to an internal portion of the HCV 59-UTR PCR
product was used to detect HCV sequences. PCR prod-
ucts were purified by PEG precipitation, washed with
95% ethanol, and sequenced directly on an ABI 377 DNA
sequencer using a Prism DyeDeoxy terminator cycle
sequencing kit (Perkin-Elmer). PCR products were
cloned into pGEM-T (Promega, USA), and both strands
were sequenced using SP6 and T7 primers, synonymous
with vector sequences. Database searches were con-
ducted using BLAST (Altschul et al., 1990). Pair-wiselignments of DNA sequences were carried out using
he GCG program GAP.ACKNOWLEDGMENTS
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